These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6791883

  • 1. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
    Shapiro W, Park J, DiBianco R, Singh SN, Katz RJ, Fletcher R.
    Chest; 1981 Oct; 80(4):425-30. PubMed ID: 6791883
    [Abstract] [Full Text] [Related]

  • 2. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ, Low RI, Paumer L, Amsterdam EA, Mason DT.
    Am J Cardiol; 1983 Jan 01; 51(1):13-8. PubMed ID: 6129794
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U, Blasini R.
    Herz; 1986 Feb 01; 11(1):55-61. PubMed ID: 2870014
    [Abstract] [Full Text] [Related]

  • 4. Nadolol compared to propranolol for treating chronic stable angina pectoris.
    Miller LA, Crawford MH, O'Rourke RA.
    Chest; 1984 Aug 01; 86(2):189-93. PubMed ID: 6146499
    [Abstract] [Full Text] [Related]

  • 5. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR, Mir MA.
    Br Heart J; 1981 Nov 01; 46(5):503-7. PubMed ID: 6119104
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
    Nikolenko SA, Metelitsa VI, Nazarenko VA, Martsevich SIu, Kulikova TV.
    Kardiologiia; 1984 Feb 01; 24(2):14-8. PubMed ID: 6143849
    [Abstract] [Full Text] [Related]

  • 7. A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
    Luther RR, Glassman HN, Jordan DC.
    J Clin Pharmacol; 1988 Jul 01; 28(7):634-9. PubMed ID: 3063728
    [Abstract] [Full Text] [Related]

  • 8. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH, Heiman M, Soberman J, Greenberg S, Eff J.
    Am J Cardiol; 1991 Apr 01; 67(8):665-70. PubMed ID: 1672481
    [Abstract] [Full Text] [Related]

  • 9. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB, Lacy CR, Krieger SD, Cosgrove NM.
    Am Heart J; 1984 Oct 01; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
    Furberg B, Dahlqvist A, Raak A, Wrege U.
    Curr Med Res Opin; 1978 Oct 01; 5(5):388-93. PubMed ID: 26520
    [Abstract] [Full Text] [Related]

  • 11. Comparison of bepridil with nadolol for angina pectoris.
    Pflugfelder PW, Humen DP, O'Brien PA, Purves PD, Jablonsky G, Kostuk WJ.
    Am J Cardiol; 1987 Jun 01; 59(15):1283-8. PubMed ID: 3296724
    [Abstract] [Full Text] [Related]

  • 12. Duration of effects of isradipine during twice daily therapy in angina pectoris.
    Thadani U, Chrysant S, Gorwit J, Giles T, Archer S, Iteld B, Singh S, Copen D, Wakeford C, Hobbs S.
    Cardiovasc Drugs Ther; 1994 Apr 01; 8(2):199-210. PubMed ID: 7918132
    [Abstract] [Full Text] [Related]

  • 13. Randomized double-blind study of pindolol in patients with stable angina pectoris.
    Harston WE, Friesinger GC.
    Am Heart J; 1982 Aug 01; 104(2 Pt 2):504-11. PubMed ID: 7102537
    [Abstract] [Full Text] [Related]

  • 14. Atenolol: once-daily cardioselective beta blockade for angina pectoris.
    Jackson G, Schwartz J, Kates RE, Winchester M, Harrison DC.
    Circulation; 1980 Mar 01; 61(3):555-60. PubMed ID: 6243518
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris.
    Kostis JB.
    Am J Cardiol; 1988 Dec 01; 62(17):1171-5. PubMed ID: 3057850
    [Abstract] [Full Text] [Related]

  • 16. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
    Winsor T, Berger HJ.
    Am Heart J; 1975 Nov 01; 90(5):611-26. PubMed ID: 811102
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K, Niitani H, Kanazawa T, Shimomura K, Toyama S.
    J Cardiovasc Pharmacol; 1986 Nov 01; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [Abstract] [Full Text] [Related]

  • 18. Celiprolol in the treatment of exercise induced angina pectoris.
    Capone P, Mayol R.
    J Cardiovasc Pharmacol; 1986 Nov 01; 8 Suppl 4():S135-7. PubMed ID: 2427844
    [Abstract] [Full Text] [Related]

  • 19. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O, Uustialo A.
    Ann Clin Res; 1975 Dec 01; 7(6):433-41. PubMed ID: 2092
    [Abstract] [Full Text] [Related]

  • 20. Angina pectoris: effective therapy once daily.
    Prager G.
    J Int Med Res; 1979 Dec 01; 7(1):39-44. PubMed ID: 33863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.